Aadi Bioscience, Inc. Profile Avatar - Palmy Investing

Aadi Bioscience, Inc.

Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimu…

Biotechnology
US, Pacific Palisades [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of AADI's Analysis
CIK: 1422142 CUSIP: 00032Q104 ISIN: US00032Q1040 LEI: - UEI: -
Secondary Listings
AADI has no secondary listings inside our databases.